Tania Blanco-Martín

12PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMedical bacteriologyMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 13, 2026
FTIR typing of the emerging NDM-14-producing Klebsiella pneumoniae ST147 clone.

|May 29, 2026
Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

|Mar 27, 2026
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

|Feb 19, 2026
Disarming carbapenemase-producing Acinetobacter baumannii: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310).

Salud Rodríguez-Pallares, Michelle Outeda-García, Emilio Lence

|Oct 21, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa.

Lucía González-Pinto, María Antonia Gomis-Font, Gloria Pérez-Rodríguez

Pageof 2

Frequent Collaborators

12 joint publications

Jorge Arca-Suárez

12 joint publications

Germán Bou

11 joint publications

Alejandro Beceiro

10 joint publications

Lucía González-Pinto